T- Vobit VX1 Tablet is a specialized pharmaceutical formulation designed to manage type 2 diabetes mellitus effectively. This innovative product combines three well-established anti-diabetic agents: Glimepiride, Metformin, and Voglibose, each contributing unique mechanisms of action to enhance blood glucose control. The primary purpose of T- Vobit VX1 Tablet is to address the multifaceted nature of type 2 diabetes, particularly when patients experience inadequate glycaemic control due to various metabolic defects. Glimepiride, a third-generation sulfonylurea, plays a crucial role in stimulating insulin secretion from functional pancreatic beta cells. By binding to sulfonylurea receptors on the membranes of these cells, T- Vobit VX1 Tablet facilitates the closure of ATP-sensitive potassium channels, leading to membrane depolarization, calcium influx, and ultimately, insulin release. This action is vital for lowering both fasting and postprandial blood glucose levels. Metformin, classified as a biguanide, is recognized as a first-line treatment for type 2 diabetes. T- Vobit VX1 Tablet Metformin component effectively reduces hepatic gluconeogenesis, enhances peripheral insulin sensitivity, and promotes glucose utilization in muscle tissue. Unlike sulfonylureas, Metformin does not stimulate insulin secretion, which minimizes the risk of hypoglycaemia when used independently. Voglibose, an alpha-glucosidase inhibitor included in T- Vobit VX1 Tablet, acts within the small intestine by inhibiting enzymes responsible for carbohydrate breakdown. This mechanism delays glucose absorption following meals and significantly mitigates postprandial blood glucose spikes. The combination of these three agents in T- Vobit VX1 Tablet is particularly advantageous as it addresses three critical contributors to hyperglycaemia: insufficient insulin secretion, insulin resistance, and excessive post-meal glucose absorption. T- Vobit VX1 Tablet is typically prescribed when lifestyle modifications and simpler anti-diabetic regimens fail to achieve desired glycaemic targets. By integrating T- Vobit VX1 Tablet into a comprehensive diabetes management plan, patients can expect improved control over their blood sugar levels and a reduction in the complications associated with uncontrolled diabetes.
Convenient combination therapy: T- Vobit VX1 Tablet reduces pill burden compared with separate medicines.
Supports long-term diabetes management: T- Vobit VX1 Tablet helps improve HbA1c when used regularly.
Addresses multiple metabolic pathways: T- Vobit VX1 Tablet is useful in progressive type 2 diabetes requiring intensified therapy.
How T- Vobit VX1 Tablet works
T- Vobit VX1 Tablet is a combination of three antidiabetic medicines: Glimepiride, Metformin, and Voglibose. These components work synergistically to provide better control of blood sugar levels when single or dual therapy is insufficient. Glimepiride increases insulin release from the pancreas to lower blood glucose levels. Metformin reduces glucose production in the liver, delays glucose absorption from the intestines, and enhances the body's sensitivity to insulin. Voglibose prevents the breakdown of complex sugars into simple sugars like glucose, thereby preventing significant rises in blood glucose levels after meals.
Glimepiride stimulates insulin secretion from pancreatic beta cells.
Metformin decreases hepatic glucose production and enhances insulin sensitivity.
Voglibose inhibits carbohydrate breakdown in the intestine.
The combination helps manage post-meal glucose spikes efficiently.
T- Vobit VX1 Tablet is particularly beneficial for patients with progressive type 2 diabetes.
How to use T- Vobit VX1 Tablet
Take T- Vobit VX1 Tablet exactly as prescribed by your healthcare provider.
T- Vobit VX1 Tablet is usually taken with meals to minimize gastrointestinal discomfort.
Swallow T- Vobit VX1 Tablet whole with a glass of water; do not chew or crush the tablet.
Avoid skipping meals while taking T- Vobit VX1 Tablet to maintain stable blood sugar levels.
Regular meal timing is essential for optimal effectiveness of T- Vobit VX1 Tablet.
Monitor blood sugar levels regularly to assess the effectiveness of T- Vobit VX1 Tablet.
The dosage of T- Vobit VX1 Tablet may vary based on individual blood glucose levels and clinical response.
Consult your doctor for any adjustments in dosage or treatment duration.
Lifestyle Advice
Avoid skipping meals to maintain stable blood sugar levels while using T- Vobit VX1 Tablet.
Carry a source of glucose for immediate relief from potential hypoglycaemia.
Regularly monitor HbA1c levels to assess long-term diabetes management with T- Vobit VX1 Tablet.
Maintain a balanced diabetic diet and incorporate regular exercise into your routine while using T- Vobit VX1 Tablet.
Attend regular medical follow-ups to adjust treatment as necessary while on T- Vobit VX1 Tablet.
Safety Advice
Side Effects
Common side effects include hypoglycaemia, especially if meals are delayed or missed.
Mild abdominal discomfort may occur during initial treatment with T- Vobit VX1 Tablet.
Flatulence is common due to delayed carbohydrate digestion by Voglibose.
Nausea may be experienced but often improves over time with continued use of T- Vobit VX1 Tablet.
Diarrhoea is frequently associated with Metformin during early treatment phases.
Serious side effects requiring immediate medical attention include severe hypoglycaemia and lactic acidosis.
Persistent nausea or jaundice may indicate liver dysfunction; consult your doctor if these symptoms arise.
Precautions and Warnings
T- Vobit VX1 Tablet should not be used by individuals with known allergies to its components.
Avoid using T- Vobit VX1 Tablet in cases of moderate to severe kidney disease or metabolic acidosis.
Alcohol consumption should be limited while taking T- Vobit VX1 Tablet due to increased risk of hypoglycaemia.
Pregnant or breastfeeding women should seek medical advice before using T- Vobit VX1 Tablet.
Caution is advised when driving or operating machinery if blood sugar levels are unstable while using T- Vobit VX1 Tablet.
Regular monitoring of liver function is recommended during treatment with T- Vobit VX1 Tablet.
FAQs
1. What is T- Vobit VX1 Tablet used for? T- Vobit VX1 Tablet is utilized for managing type 2 diabetes mellitus when blood sugar levels are not adequately controlled with fewer medications. It aids in improving both fasting and post-meal glucose levels through its three complementary actions.
2. Why are three medicines combined in one tablet? The combination of three medicines in T- Vobit VX1 Tablet allows for different mechanisms to enhance glucose control. Together, they effectively address issues related to insulin deficiency, insulin resistance, and delayed carbohydrate absorption.
3. Can T- Vobit VX1 Tablet cause hypoglycaemia? Yes, the Glimepiride component in T- Vobit VX1 Tablet may lead to low blood sugar levels, particularly if meals are delayed or missed. Maintaining regular meal timing can help mitigate this risk.
4. Should T- Vobit VX1 Tablet be taken with food? Yes, it is recommended to take T- Vobit VX1 Tablet with meals to reduce gastrointestinal discomfort and enhance post-meal glucose control.
5. Does Voglibose reduce post-meal blood sugar? Yes, Voglibose included in T- Vobit VX1 Tablet delays carbohydrate digestion in the intestine, which helps lower the rise in blood glucose after meals.
6. Can Metformin cause stomach upset? Mild gastrointestinal symptoms such as nausea or abdominal discomfort may occur during the initial stages of treatment with Metformin in T- Vobit VX1 Tablet but often improve as the body adjusts.
7. Is T- Vobit VX1 Tablet safe for long-term use? Yes, T- Vobit VX1 Tablet is commonly prescribed for long-term diabetes management under regular monitoring of blood sugar levels.
8. Can alcohol be taken while using T- Vobit VX1 Tablet? Alcohol consumption should be limited while taking T- Vobit VX1 Tablet due to its potential to increase the risk of hypoglycaemia and lactic acidosis.
9. Can people with kidney disease take T- Vobit VX1 Tablet? Patients with kidney disease should have their kidney function assessed before and during treatment with T Vobit VX1 Tablet since Metformin may accumulate if renal function is impaired.
10. Can T- Vobit VX1 Tablet replace insulin? T- Vobit VX1 Tablet is used for type 2 diabetes when oral treatment remains appropriate; however, insulin may still be necessary in advanced cases.
11. What should I do if I miss a dose? If you miss a dose of T- Vobit VX1 Tablet, take it with your next meal if remembered soon but do not take an extra dose to compensate.
12. Can weight changes occur with T- Vobit VX1 Tablet? Mild weight variations may occur depending on factors such as glucose control and dietary habits while using T- Vobit VX1 Tablet.
13. Is exercise still necessary while taking T- Vobit VX1 Tablet? Yes, regular exercise remains crucial as it enhances the effectiveness of treatment with T- Vobit VX1 Tablet.
14. Can elderly patients take T- Vobit VX1 Tablet? Elderly patients can use T- Vobit VX1 Tablet under careful medical supervision, especially regarding kidney function monitoring.
15. How should T- Vobit VX1 Tablet be stored? Store T- Vobit VX1 Tablet in a cool, dry place away from moisture and direct sunlight, ensuring it remains out of reach of children.
Instructions
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
More Information
SKU
401900
Country of Manufacture
India
Manufacturer Address
Lupin Limited
Return/Buy Back policy
Non-returnable
Prescription Required
Yes
Storage
Please refer to the product label for storage information.
T- Vobit VX1 Tablet is a specialized pharmaceutical formulation designed to manage type 2 diabetes mellitus effectively. This innovative product combines three well-established anti-diabetic agents: Glimepiride, Metformin, and Voglibose, each contributing unique mechanisms of action to enhance blood glucose control. The primary purpose of T- Vobit VX1 Tablet is to address the multifaceted nature of type 2 diabetes, particularly when patients experience inadequate glycaemic control due to various metabolic defects. Glimepiride, a third-generation sulfonylurea, plays a crucial role in stimulating insulin secretion from functional pancreatic beta cells. By binding to sulfonylurea receptors on the membranes of these cells, T- Vobit VX1 Tablet facilitates the closure of ATP-sensitive potassium channels, leading to membrane depolarization, calcium influx, and ultimately, insulin release. This action is vital for lowering both fasting and postprandial blood glucose levels. Metformin, classified as a biguanide, is recognized as a first-line treatment for type 2 diabetes. T- Vobit VX1 Tablet Metformin component effectively reduces hepatic gluconeogenesis, enhances peripheral insulin sensitivity, and promotes glucose utilization in muscle tissue. Unlike sulfonylureas, Metformin does not stimulate insulin secretion, which minimizes the risk of hypoglycaemia when used independently. Voglibose, an alpha-glucosidase inhibitor included in T- Vobit VX1 Tablet, acts within the small intestine by inhibiting enzymes responsible for carbohydrate breakdown. This mechanism delays glucose absorption following meals and significantly mitigates postprandial blood glucose spikes. The combination of these three agents in T- Vobit VX1 Tablet is particularly advantageous as it addresses three critical contributors to hyperglycaemia: insufficient insulin secretion, insulin resistance, and excessive post-meal glucose absorption. T- Vobit VX1 Tablet is typically prescribed when lifestyle modifications and simpler anti-diabetic regimens fail to achieve desired glycaemic targets. By integrating T- Vobit VX1 Tablet into a comprehensive diabetes management plan, patients can expect improved control over their blood sugar levels and a reduction in the complications associated with uncontrolled diabetes.
Convenient combination therapy: T- Vobit VX1 Tablet reduces pill burden compared with separate medicines.
Supports long-term diabetes management: T- Vobit VX1 Tablet helps improve HbA1c when used regularly.
Addresses multiple metabolic pathways: T- Vobit VX1 Tablet is useful in progressive type 2 diabetes requiring intensified therapy.
How T- Vobit VX1 Tablet works
T- Vobit VX1 Tablet is a combination of three antidiabetic medicines: Glimepiride, Metformin, and Voglibose. These components work synergistically to provide better control of blood sugar levels when single or dual therapy is insufficient. Glimepiride increases insulin release from the pancreas to lower blood glucose levels. Metformin reduces glucose production in the liver, delays glucose absorption from the intestines, and enhances the body's sensitivity to insulin. Voglibose prevents the breakdown of complex sugars into simple sugars like glucose, thereby preventing significant rises in blood glucose levels after meals.
Glimepiride stimulates insulin secretion from pancreatic beta cells.
Metformin decreases hepatic glucose production and enhances insulin sensitivity.
Voglibose inhibits carbohydrate breakdown in the intestine.
The combination helps manage post-meal glucose spikes efficiently.
T- Vobit VX1 Tablet is particularly beneficial for patients with progressive type 2 diabetes.
How to use T- Vobit VX1 Tablet
Take T- Vobit VX1 Tablet exactly as prescribed by your healthcare provider.
T- Vobit VX1 Tablet is usually taken with meals to minimize gastrointestinal discomfort.
Swallow T- Vobit VX1 Tablet whole with a glass of water; do not chew or crush the tablet.
Avoid skipping meals while taking T- Vobit VX1 Tablet to maintain stable blood sugar levels.
Regular meal timing is essential for optimal effectiveness of T- Vobit VX1 Tablet.
Monitor blood sugar levels regularly to assess the effectiveness of T- Vobit VX1 Tablet.
The dosage of T- Vobit VX1 Tablet may vary based on individual blood glucose levels and clinical response.
Consult your doctor for any adjustments in dosage or treatment duration.
Lifestyle Advice
Avoid skipping meals to maintain stable blood sugar levels while using T- Vobit VX1 Tablet.
Carry a source of glucose for immediate relief from potential hypoglycaemia.
Regularly monitor HbA1c levels to assess long-term diabetes management with T- Vobit VX1 Tablet.
Maintain a balanced diabetic diet and incorporate regular exercise into your routine while using T- Vobit VX1 Tablet.
Attend regular medical follow-ups to adjust treatment as necessary while on T- Vobit VX1 Tablet.
Side Effects
Common side effects include hypoglycaemia, especially if meals are delayed or missed.
Mild abdominal discomfort may occur during initial treatment with T- Vobit VX1 Tablet.
Flatulence is common due to delayed carbohydrate digestion by Voglibose.
Nausea may be experienced but often improves over time with continued use of T- Vobit VX1 Tablet.
Diarrhoea is frequently associated with Metformin during early treatment phases.
Serious side effects requiring immediate medical attention include severe hypoglycaemia and lactic acidosis.
Persistent nausea or jaundice may indicate liver dysfunction; consult your doctor if these symptoms arise.
Precautions and Warnings
T- Vobit VX1 Tablet should not be used by individuals with known allergies to its components.
Avoid using T- Vobit VX1 Tablet in cases of moderate to severe kidney disease or metabolic acidosis.
Alcohol consumption should be limited while taking T- Vobit VX1 Tablet due to increased risk of hypoglycaemia.
Pregnant or breastfeeding women should seek medical advice before using T- Vobit VX1 Tablet.
Caution is advised when driving or operating machinery if blood sugar levels are unstable while using T- Vobit VX1 Tablet.
Regular monitoring of liver function is recommended during treatment with T- Vobit VX1 Tablet.
1. What is T- Vobit VX1 Tablet used for? T- Vobit VX1 Tablet is utilized for managing type 2 diabetes mellitus when blood sugar levels are not adequately controlled with fewer medications. It aids in improving both fasting and post-meal glucose levels through its three complementary actions.
2. Why are three medicines combined in one tablet? The combination of three medicines in T- Vobit VX1 Tablet allows for different mechanisms to enhance glucose control. Together, they effectively address issues related to insulin deficiency, insulin resistance, and delayed carbohydrate absorption.
3. Can T- Vobit VX1 Tablet cause hypoglycaemia? Yes, the Glimepiride component in T- Vobit VX1 Tablet may lead to low blood sugar levels, particularly if meals are delayed or missed. Maintaining regular meal timing can help mitigate this risk.
4. Should T- Vobit VX1 Tablet be taken with food? Yes, it is recommended to take T- Vobit VX1 Tablet with meals to reduce gastrointestinal discomfort and enhance post-meal glucose control.
5. Does Voglibose reduce post-meal blood sugar? Yes, Voglibose included in T- Vobit VX1 Tablet delays carbohydrate digestion in the intestine, which helps lower the rise in blood glucose after meals.
6. Can Metformin cause stomach upset? Mild gastrointestinal symptoms such as nausea or abdominal discomfort may occur during the initial stages of treatment with Metformin in T- Vobit VX1 Tablet but often improve as the body adjusts.
7. Is T- Vobit VX1 Tablet safe for long-term use? Yes, T- Vobit VX1 Tablet is commonly prescribed for long-term diabetes management under regular monitoring of blood sugar levels.
8. Can alcohol be taken while using T- Vobit VX1 Tablet? Alcohol consumption should be limited while taking T- Vobit VX1 Tablet due to its potential to increase the risk of hypoglycaemia and lactic acidosis.
9. Can people with kidney disease take T- Vobit VX1 Tablet? Patients with kidney disease should have their kidney function assessed before and during treatment with T Vobit VX1 Tablet since Metformin may accumulate if renal function is impaired.
10. Can T- Vobit VX1 Tablet replace insulin? T- Vobit VX1 Tablet is used for type 2 diabetes when oral treatment remains appropriate; however, insulin may still be necessary in advanced cases.
11. What should I do if I miss a dose? If you miss a dose of T- Vobit VX1 Tablet, take it with your next meal if remembered soon but do not take an extra dose to compensate.
12. Can weight changes occur with T- Vobit VX1 Tablet? Mild weight variations may occur depending on factors such as glucose control and dietary habits while using T- Vobit VX1 Tablet.
13. Is exercise still necessary while taking T- Vobit VX1 Tablet? Yes, regular exercise remains crucial as it enhances the effectiveness of treatment with T- Vobit VX1 Tablet.
14. Can elderly patients take T- Vobit VX1 Tablet? Elderly patients can use T- Vobit VX1 Tablet under careful medical supervision, especially regarding kidney function monitoring.
15. How should T- Vobit VX1 Tablet be stored? Store T- Vobit VX1 Tablet in a cool, dry place away from moisture and direct sunlight, ensuring it remains out of reach of children.
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
SKU
401900
Country of Manufacture
India
Manufacturer Address
Lupin Limited
Return/Buy Back policy
Non-returnable
Prescription Required
Yes
Storage
Please refer to the product label for storage information.
